Publications

Export 184 results:
Sort by: Author [ Title  (Asc)] Type Year
A B C D E F G H I [J] K L M N O P Q R S T U V W X Y Z   [Show ALL]
J
Abdelrahman, E. M., and T. M. El-Araby, "J KAU: Elm/i S111. vol. 9. pp I7-27 (l4l6-I418 AH I 1996-I997 AD.)", Majallat J{\=a}miʻat Al-Malik ʻAbd Al-ʻAz{\=ız, vol. 9: Scientific Publishing Centre, King Abdulaziz University, pp. 17, 1996. Abstract
n/a
Grace, S. R., R. P. Agarwal, and D. O’Regan, J. Adv. Math. Stud., , Submitted. Abstract
n/a
Grace, S. R., R. P. Agarwal, and D. O’Regan, J. Adv. Math. Stud., , Submitted. Abstract
n/a
Hussein, A. M., S. S. M., and A. A. Atalla, "J. Chem. Res. (S), 356 (1996); (M), 1970", Monatsch. Chem., 127, 1153 , 1996.
Ibrahim, Y. A., A. H. M. Elwahy, A. A. Abbas, and R. M. Kassab, J. Chem. Res.(S), , 1998. Abstract
n/a
Ibrahim, Y. A., A. H. M. Elwahy, A. A. Abbas, and R. M. Kassab, J. Chem. Res.(S), , 1998. Abstract
n/a
Dawood, K. M., E. A. Ragab, and A. M. Farag, J. Chem. Res.,(S), , 2003. Abstract
n/a
Chatrchyan, S., V. Khachatryan, A. M. Sirunyan, A. Tumasyan, W. Adam, T. Bergauer, M. Dragicevic, J. Erö, C. Fabjan, M. Friedl, et al., "J/ψ and ψ (2S) production in pp collisions at √s = 7 TeV", Journal of High Energy Physics, vol. 2012, no. 2, 2012. AbstractWebsite
n/a
, "J/ψ and ψ (2S) production in pp collisions at √s = 7 TeV", Journal of High Energy Physics, vol. 2012, no. 2, 2012. AbstractWebsite
n/a
Bassyouni, I. H., M. A. Mashahit, R. H. Bassyouni, N. Ibrahim, N. A. El-Sherbiny, and E. El-Tahlawy, "Jaccoud", Journal of Advanced Research, 2011. Abstract

IF: 3.00

Hafez, R. M., and Y. H. Youssri, "Jacobi collocation scheme for variable-order fractional reaction-subdiffusion equation", Computational and Applied Mathematics, vol. 37, no. 4, pp. 5315-5333, 2018. AbstractWebsite
n/a
Doha, E. H., A. H. Bhrawy, and R. M. Hafez, "A Jacobi Dual-Petrov-Galerkin Method for Solving Some Odd-Order Ordinary Differential Equations", Abstract and Applied Analysis, 2011.
Kumar, S. V., H. Rezazadeh, M. Eslami, F. Izadi, and M. S. Osman, "Jacobi Elliptic Function Expansion Method for Solving KdV Equation with Conformable Derivative and Dual-Power Law Nonlinearity", International Journal of Applied and Computational Mathematics, vol. 5, pp. 127, 2019.
Hafez, R. M., Y. H. Youssri, and A. G. Atta, "Jacobi Rational Operational Approach for Time-Fractional Sub-Diffusion Equation on a Semi-Infinite Domain", Contemporary Mathematics (Singapore), vol. 4, no. 4, pp. 853 – 876, 2023. AbstractWebsite
n/a
Bhrawy, A. H., and A. S. Alofi, "A Jacobi–Gauss collocation method for solving nonlinear Lane–Emden type equations", Communications in Nonlinear Science and Numerical Simulation, vol. 17, no. 1: Elsevier, pp. 62–70, 2012. Abstract
n/a
Benchohra, M., J. Henderson, S. K. NTOUYAS, R. P. Agarwal, S. R. Grace, G. GIACOMOBONO, and I. V. A. N. K. A. M. STAMOVA, "JAHAN EFTEKHAR, RAMON NAVARRO, and BETTY TRAVIS", Mathematical Sciences Research Journal, vol. 6: Global Publishing Company, pp. 589, 2002. Abstract
n/a
Menshawey, R., EsraaMenshawey, A. H. K. Alserr, and A. F. AbdelMassih, "JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations.", Cardiovascular endocrinology & metabolism, vol. 10, issue 2, pp. 80-88, 2021. Abstract

The adaptive use of Janus kinase (JAK)-inhibitors has been suggested by rheumatology experts in the management of COVID-19. We recount the rationale behind their use in this setting, and the current evidence for and against their use in this review. JAK-inhibitors role in COVID-19 infection appears to be multifaceted, including preventing viral endocytosis and dampening the effect of excessive chemokines. This drug class may be able to achieve these effects at already preapproved dosages. Concerns arise regarding reactivation of latent viral infections and the feasibility of their use in those with severe disease. Most interestingly, JAK-Inhibitors may also have an additional advantage for diabetic and obese populations, where the dysregulation of JAK-signal transducer and activator of transcription pathway may be responsible for their increased risk of poor outcomes. Targeting this pathway may provide a therapeutic advantage for these patient groups.

Sayed, K. S., M. H. M. El-Komy, H. Shehata, S. H. ElShazly, E. D. ElDesouky, K. S. Amr, N. M. ElAraby, and A. M. AlOrbani, "JAK1 rs310241 and JAK3 rs3008 genotypes may increase susceptibility to psoriasis: a case control study", Skin Pharmacology and Physiology, vol. 33, issue 4: Karger Publishers, pp. 207-212, 2020. Abstract
n/a
Sayed, K. S., M. H. M. El-Komy, H. Shehata, S. H. ElShazly, E. D. ElDesouky, K. S. Amr, N. M. ElAraby, and A. M. AlOrbani, "JAK1 rs310241 and JAK3 rs3008 Genotypes May Increase Susceptibility to Psoriasis: A Case Control Study.", Skin pharmacology and physiology, vol. 33, issue 4, pp. 207-212, 2020. Abstract

BACKGROUND: Janus kinases (JAKs) are a family of non-receptor protein tyrosine kinases that are expressed in a variety of tissues. Several JAK-controlled cytokine receptor pathways are incriminated in the initiation and progression of psoriasis. Genetic polymorphisms influencing JAK expression would be anticipated to have a great impact on disease activity.

OBJECTIVE: The aim of the study was to evaluate the association between JAK1 rs310241 and JAK3 rs3008 polymorphisms and the risk of developing psoriasis.

METHODS: Blood samples of 150 patients and 120 controls were screened for nucleotide polymorphisms in JAK1 rs310241 and JAK3 rs3008 genes by using polymerase chain reaction (PCR)-restriction fragment length polymorphism technique.

RESULTS: The GG genotype of the JAK1 rs310241 and JAK3 rs3008 genes was significantly associated with an increase in psoriasis risk (p = 0.000, OR = 7.7, 95% CI = 2.8-21.5; p = 0.003, OR = 3.3, 95% CI = 1.5-6.9, respectively). The G allele of both genes was also associated with psoriasis susceptibility (p = 0.000, OR = 2.0, 95% CI = 1.4-2.8; p = 0.002, OR = 1.7, 95% CI = 1.2-2.4, respectively).

CONCLUSION: The results indicate a possible association between JAK1 rs310241 and JAK3 rs3008 gene polymorphisms and susceptibility to psoriasis. These findings validate the importance of these molecules in psoriasis and may enable the identification of the individuals most susceptible to the disease.

Khattab, S., D. Mosse, and R. Melhem, "Jamming mitigation in multi-radio wireless networks: Reactive or proactive?", Proceedings of the 4th international conference on Security and privacy in communication netowrks: ACM, pp. 27, 2008. Abstract
n/a
Khattab, S., D. Mosse, and R. Melhem, "Jamming mitigation in multi-radio wireless networks: Reactive or proactive?", Proceedings of the 4th international conference on Security and privacy in communication netowrks, pp. 1–10, 2008. Abstract
n/a
Tourism